The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
NCT00002336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2015-01-16
Summary
To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.
Conditions
- Mycobacterium Avium-intracellular Infection
- HIV Infections
Interventions
- DRUG
-
Clarithromycin
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1992-11-30
- Primary Completion
- 1994-11-30
- Completion
- 1994-11-30
Countries
- United States
Study Locations
More Related Trials
-
Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048
NCT00000933 ·Status: COMPLETED
-
An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)
NCT00002090 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy
NCT00002089 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
NCT00000947 ·Status: COMPLETED ·Phase: NA
-
Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS
NCT00001047 ·Status: COMPLETED ·Phase: PHASE3
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002267 ·Status: COMPLETED ·Phase: NA
-
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
NCT00002101 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
NCT00002192 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS
NCT00000971 ·Status: COMPLETED ·Phase: PHASE1
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002032 ·Status: COMPLETED ·Phase: NA
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study
NCT00002080 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
NCT00001039 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
NCT00001995 ·Status: COMPLETED ·Phase: NA
-
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
NCT00002122 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS
NCT00002343 ·Status: COMPLETED ·Phase: PHASE4
-
Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
NCT00002082 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease
NCT00002058 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection
NCT00000895 ·Status: COMPLETED ·Phase: NA
-
A Study of Azithromycin in HIV-Infected Patients
NCT00002344 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
NCT00000641 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
NCT00002139 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Lobucavir in Patients With AIDS
NCT00002352 ·Status: COMPLETED ·Phase: NA
-
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
NCT00000966 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites
NCT00000826 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients
NCT01227395 ·Status: COMPLETED